Eating healthier can protect aging brain

Research led by Aarhus University in Denmark reports that individuals with substance use disorders experience a heightened urge to move in response to music with complex rhythms and harmonies.

The Experimental Drug Development Center (EDDC), Singapore's national platform for drug discovery and development, has announced the presentation of updated clinical data for the ongoing Phase I trial for EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Routine testing for multiple infectious diseases among migrants will benefit health care systems by identifying key infections earlier, a new study finds.

Spending time in or around nature can provide people suffering from chronic lower back pain with a degree of escapism that helps them better manage their physical discomfort, a new study has shown.

The effects of artificial intelligence on adolescents are nuanced and complex, according to a report from the American Psychological Association that calls on developers to prioritize features that protect young people from exploitation, manipulation and the erosion of real-world relationships.

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in npj Vaccines.

Thousands more UK women who are having children have been diagnosed with an autoimmune condition now compared to the beginning of the millennium.

Extremely preterm newborns who weigh less than 3.3 pounds have immature lungs that often require high levels of ventilation oxygen in the hospital. This contributes to the chronic lung disease bronchopulmonary dysplasia, or BPD, the most common cause of death for these tiny infants. BPD exacts a devastating toll on the immature lung.

02 June 2025 Your Excellency, Dr Khaled Abdel Ghaffar, Minister of Health and Population of Egypt, Distinguished officials, Representatives of the Egyptian Vaccine Manufacturers Alliance, Colleagues and Partners, On behalf of the World Health Organization, I extend my warmest congratulations to Egypt for becoming the first country in the Eastern Mediterranean Region to achieve the regional target for hepatitis B control, as set by the Regional Committee Resolution EM/RC56/R.5 (2009). This recognition follows a rigorous review led by the independent Regional Validation Committee (RVC). Based on robust and verifiable data, the RVC concluded that Egypt has indeed met the regional target, supported by the following key indicators: Hepatitis B surface antigen (HBsAg) prevalence among children aged 5 years and older is below 1 per cent; Third-dose hepatitis B vaccine coverage maintained at 90 per cent or higher for over a decade; And birth dose coverage has exceeded 90 per cent for at least five years. These achievements are a testament to your leadership, sustained investment, and steadfast commitment to public health. I commend Your Excellency, the Ministry of Health and Population, and the dedicated teams driving Egypt’s national immunization and hepatitis control programmes. Egypt’s success represents not only a national achievement, but a regional milestone—a powerful example of what is possible when science, policy, and public trust align. Through your strong Expanded Programme on Immunization, you have significantly reduced vaccine-preventable diseases, improved child survival, and strengthened health systems—culminating in the elimination of measles and rubella. WHO stands ready to support you in introducing additional life-saving vaccines to protect against rotavirus, human papillomavirus, Read more...

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response rates for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), according to data from a Phase I/II study led by researchers from The University of Texas MD Anderson Cancer Center.

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, the oral proteolysis-targeting chimera ER degrader, vepdegestrant, leads to significantly longer progression-free survival in patients with ESR1 mutations, according to a study published online May 31 in the New England Journal of Medicine. The research was presented to coincide with the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.

Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment approach is currently being evaluated in the CompassHER2 pCR trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).

Salmonella-tainted tomatoes in three southern states could cause severe illness or even death, the U.S. Food and Drug Administration (FDA) warns.

In a new clinical practice guideline issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and published online May 27 in Otolaryngology-Head and Neck Surgery, recommendations are presented for the surgical management of chronic rhinosinusitis in adults.

When physicians receive relative performance feedback on quality of care, the design of the ranking influences whether it motivates them to improve or has a demotivating effect. The specified quality threshold defining outstanding performance and top ranks may not be set too low, nor must it be too difficult to achieve.

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according to a study published online May 13 in JEADV Clinical Practice.

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing multiple myeloma, the second most common type of blood cancer. The study showed that the diet was not only feasible and well-received but also improved several factors that could potentially delay the progression of precancerous conditions that can lead to multiple myeloma.

As artificial intelligence (AI) continues to be integrated into health care, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in diagnostics. The verdict? Patients are cautiously optimistic, welcoming the potential benefits of AI but drawing a firm line: humans must stay in charge.